Group B Streptococcus (GBS) infections

Updated: July 22, 2024

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

pneumococcal vaccine 20-valent

Administer dose of 0.5 ml intramuscularly for one time a day

pneumococcal vaccine 20-valent

Aged 6 weeks through 15 months
4-dose series:
Administer dose of 0.5 ml intramuscularly at 2 months, 4 months, 6 months and then for 12 to 15 months
First dose may be given as early as possible at time of 6 weeks of age Individuals starting vaccination at aged 7 months through 17 years old 7 to 11 months: as 3 dose series
Administer first 2 doses minimum four weeks apart and then third dose after 1 year, apart from the second dose by at least 2 months
12 to 23 months: as 2 doses series
Administer minimum 2 months apart
>24 months: Administer 1 dose

Future Trends